We are live on ! Find out more
SMTI icon

Sanara MedTech

51 hedge funds and large institutions have $31.6M invested in Sanara MedTech in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 5

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

29% more capital invested

Capital invested by funds: $24.5M → $31.6M (+$7.13M)

16% more funds holding

Funds holding: 4451 (+7)

1.64% more ownership

Funds ownership: 9.26%10.9% (+1.6%)

Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
24
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WIA
51
World Investment Advisors
California
-$638K -21,112 Closed
Lazard Asset Management
52
Lazard Asset Management
New York
-$258K -7,595 -100%
SO
53
STRS Ohio
Ohio
-$48.4K -1,600 Closed

SMTI Hedge Fund Activity: Q4 2024 in Review

51 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2024, worth a combined $31.6M — up 29% from $24.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new SMTI positions and 2 closed out — a net gain of 7 holders — while 24 added to existing stakes and 5 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.03M. The largest seller was World Investment Advisors, exiting entirely with an estimated $638K sold.

  • 51 institutional investors held Sanara MedTech (SMTI) as of Q4 2024, up from 44 in Q3 2024.
  • Funds reported $31.6M of Sanara MedTech stock for Q4 2024, up 29% quarter-over-quarter.
  • 9 funds opened new Sanara MedTech positions in Q4 2024 and 2 closed out, a net change of +7 holders.
  • The largest Sanara MedTech buyer in Q4 2024 was Marshall Wace, an estimated $1.03M added.
  • The largest Sanara MedTech seller in Q4 2024 was World Investment Advisors, an estimated $638K sold.

Based on aggregated 13F filings for Q4 2024.